Pharmaceutical giant Sanofi to invest €400 million in Singapore vaccine plant
The high-tech factory which will be able to produce several vaccines at once is expected to be operational in early 2026.
Sanofi, GSK vaccines only ready at end-2021
Interim results showed a low immune response in older adults.
In new breakthrough, Moderna’s Covid-19 vaccine nearly 95% effective
Moderna plans to submit applications for emergency approval around the world within weeks.
Sanofi says its vaccine won’t need supercooling
Maintaining the 'ultra-cold chain' from factory to patients is expected to present an enormous logistical challenge.
